Tumor cells derived from high-risk patients have deletion of chromosome 17 (del 17), on which the p53 tumor suppressor gene is located, deletion of chromosome 13 or chromosomal translocation t(4;14) accompanied with constitutive activation of FGFR-3 on chromosome 4 [9]–[11]. The gene discussed is FGFR3; the disease is neoplasm.